Fig. 1: The injectable, self-healing, pH/ROS dual-responsive, polycationic hydrogel reversed TMJOA and alleviated chronic pain by inhibiting neurovascularization at osteochondral interface.
Be bevacizumab, VEGF vascular endothelial growth factor, exRNA extracellular ribonucleic acid, VEGFR VEGF receptor. Created in BioRender.
